Loargys® (pegzilarginase-nbln)
| Full Name | Loargys® (pegzilarginase-nbln) |
| Drug | pegzilarginase |
| Manufacturer | Immedica Pharma |
| Route of Administration | Intravenous or Subcutaneous |
| Site of Care | Healthcare Facility |
| Approved Indication | LOARGYS is an arginine specific enzyme indicated for the treatment of hyperargininemia in adult and pediatric patients 2 years of age and older with Arginase 1 Deficiency (ARG1-D), in conjunction with dietary protein restriction. |
| Disease | Arginase 1 Deficiency (ARG1-D); Urea Cycle Disorders (UCDs) |
| Therapeutic Area | Metabolic Disorder |
| Enrollment Form | Enrollment Form |
| Phone Number | 844-982-5691, select option 2 |
| Fax Number | 844-982-5693 |
| Product Website | loargys.com |
| Patient Resources | flok |